The Latest Breaking News on Mental health

The results of a new trial were labelled as symbolic of ‘a new era where Alzheimer’s disease could become treatable’

New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening

In a large study, the experimental drug donanemab slowed the progression of Alzheimer's by about 35%. That's slightly better than the drug Leqembi, which was fully approved by the FDA on July 6.

While it is not a cure, proof that drugs can alter course of disease is regarded as significant triumph

Exclusive: As results show 35% slowing in cognitive decline, health leaders say swift decisions crucial

Single-sided deafness (SSD) is a hearing impairment that affects at least one in every 1,000 babies born. These infants have severe-to-profound hearing loss in one ear with normal or near-normal hearing in the other ear. The condition can also develop in older children and adults.

Ranchi Univ. has its own Radio Khanchi 90.4 FM, providing academic info & lectures to students. It also focuses on health & society awareness campaigns.

Sleep disturbance is a recognised risk factor for developing a host of psychiatric disorders. Going to bed is the best thing you can do for your brain right now

Disappointed reader concludes that either they didn’t care, no one cared, or they were for some reason afraid to see someone with the disease

Eisai Co.’s breakthrough Alzheimer’s drug — the first to show it slows the brain-destroying disease — is facing a rocky rollout as doctors grapple with logistical issues, insurance uncertainties and complicated safety testing requirements.

As advanced remedies emerge, the chief executive of Alzheimer’s Research UK warns sufferers could miss out as the health service struggles to cope